RecruitingPhase 3NCT05812807Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabSponsor: Alliance for Clinical Trials in OncologyAlbemarle, NC · Asheboro, NC · +825 more sites
RecruitingPhase 3NCT04852887De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Sponsor: NRG OncologyAlbemarle, NC · Asheville, NC · +809 more sites
RecruitingPhase 3NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerSponsor: SWOG Cancer Research NetworkAsheboro, NC · Asheville, NC · +952 more sites